Sugar-based Excipients Market Set to Flourish, Fueled by Growing Pharmaceutical Demand and Advancements in Drug Delivery Systems

Sugar-based Excipients Market
Sugar-based Excipients Market

The global market for sugar-based excipients is poised for significant growth, driven by factors such as the increased utilization of co-processed excipients, advancements in orally disintegrating tablets (ODTs), and rising demand for pharmaceutical formulations aimed at improving bioavailability and stability.

According to recent market projections, the global sugar-based excipients market is expected to reach a value of US$ 1068.41 million by 2023, with a compound annual growth rate (CAGR) of 4.8%. By 2033, the market is estimated to exceed US$ 1707.46 million, indicating substantial growth potential over the forecast period.

Key factors driving the growth of the sugar-based excipients market include the growing popularity of co-processed excipients in the pharmaceutical industry due to their cost-effectiveness and versatility in drug delivery systems. Co-processed excipients are increasingly being utilized to enhance the bioavailability, dissolution, and disintegration of Active Pharmaceutical Ingredients (API), thereby improving the efficacy of pharmaceutical formulations.

Request Sample Report and Drive Impactful Decisions:

Furthermore, the rise in demand for orally disintegrating tablets (ODTs) has contributed to the market growth, as sugar-based excipients are widely used in the formulation of ODTs. These tablets dissolve on the tongue, providing a convenient and attractive option for patients, particularly children and the elderly, who may have difficulty swallowing traditional tablets.

Increasing utilization of co-processed excipients, patent cliffs for sugar excipients, and advancements in orally disintegrating tablets (ODTS) are factors driving sugar-based excipients market growth. says a lead analyst at Future Market Insights.

Key Takeaways from Market Study

  • The sugar-based excipients market is expected to grow at a CAGR of 4.8% over the forecast period.
  • According to estimates, the sugar-based excipients market in North America will remain strong throughout the length of the forecast period.
  • In terms of type, the powder segment accounts for a significant share of the market since it is widely used in pharmaceutical applications.
  • The actual sugar segment is projected to reach a revenue share of US$ 750.5 million by 2033 and is expected to expand at a CAGR of 4.4%.
  • The U.S. sugar-based excipients market is expected to record a CAGR of 3.5% during the forecast period.
  • China’s sugar-based excipients market is projected to reach revenues of US$ 258.5 million by 2033. This is expected to deliver the fastest CAGR of 6.7%.

Competitive Landscape:

Several prominent companies dominate this market, including Ashland Inc., Associated British Foods Plc, BASF SE, Colorcon, Inc., Cargill, Inc., DFE Pharma, FMC Corporation, MEGGLE AG, Roquette Group, and The Lubrizol Corporation and others.

Unlock Insights: Request Your Customizable Report Today:

Excipient companies engage in a variety of key activities, including product launches, expansions, and distribution network expansions, as well as establishing global footprints through subsidiaries and partnerships.

Using these activities, manufacturers can gain a larger share of the market, expand their product portfolios, and expand their reach to different regions. They can also gain access to new markets and advanced technologies through partnerships with other companies. Major players also acquire companies, merge, and diversify their portfolios.

Recent Developments:

  • In September 2022, Roquette acquired Crest Cellulose, an Indian company that manufactures pharmaceutical and nutraceutical excipients. By acquiring Crest Cellulose, Roquette is gaining access to a larger market and expanding its portfolio of excipients. This acquisition gives Roquette a more comprehensive range of excipients and allows Roquette to gain more market share in India.
  • In July 2022, DFE Pharma introduced Lactohale 400, a lactose-free, non-GMO, plant-based excipient that can be used in tablets, capsules, and granules. It is a lactose-free, non-GMO, plant-based excipient. To meet the increasing demand for natural, sustainable excipients in the nutraceutical and pharmaceutical industries, the product was developed.
  • The Roquette Group (France) has developed a wide range of sugar-based excipients that are proven to work in the industry. In Lestrem, France, the Roquette Group opened a pharmaceutical application development center. With this upgraded facility, the company was able to develop excipients and active ingredients more effectively.
  • For the growing demand for excipient products as well as services in Shanghai, China, DFE Pharma (Germany) opened a new sales office.

Gain Immediate Access to Detailed Market Insights Purchase Now:

Sugar-based Excipients by Category

By Product, the Sugar-based Excipients Market is Segmented as:

  • Actual Sugar
  • Sugar alcohols
  • Artificial sweeteners

By Type, the Sugar-based Excipients Market is Segmented as:

  • Powders
  • Direct Compression Sugars
  • Crystals
  • Syrups
  • Others

By Functionality, the Sugar-based Excipients Market is Segmented as:

  • Fillers and Diluents
  • Flavoring Agents
  • Tonicity Agents
  • Others

By Formulation, Sugar-based Excipients are Segmented as:

  • Oral
  • Parenteral
  • Topical
  • Others

By Region, Sugar-based Excipients are Segmented as:

  • North America
  • Latin America
  • Europe
  • The Middle East and Africa
  • East Asia

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

 Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries:
LinkedInTwitterBlogs | YouTube

Leave a comment

Your email address will not be published. Required fields are marked *